• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    40.06 Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:40.06
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:43.50
    Beta:1.95
    Earnings Date:Feb 11 - Feb 16 (Est.)
    Day's Range:N/A - N/A
    52wk Range:27.51 - 40.58
    Volume:0
    Avg Vol (3m):755,103
    Market Cap:1.65B
    P/E (ttm):72.97
    EPS (ttm):0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACOR 0.00%1.65B
    BIIB85.17B
    TEVA49.58B

    Key Statistics

    Forward P/E (1 yr):143.07
    P/S (ttm):4.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.49
    Quarterly EPS Est (Dec-14) :0.08
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback